Sign Up Now to Download a Free Research Report on

Sign-Up to Get the Equity Report on this Company Plus Exclusive Access to Our Winning Newsletter Alerts




Download Adobe Reader Having problems viewing PDF files? Download Adobe Reader.

OXiGENE, Inc.

OXiGENE shares of the biotech company were sent soaring after reporting the combination of ZYBRESTAT and Avastin has again demonstrated acceptable tolerability in a second interim and final toxicity analysis. OXiGENE posted a gain of nearly 20 percent on over 1 million shares traded Thursday.

Going forward .... (see research report)



RESEARCH REPORT ON Download Free Report Now


Preview Pages of Actual Equity Report

Download Adobe Reader Having problems viewing PDF files? Download Adobe Reader. Research Report on    Research Report on    Research Report on    

Research Report on    Research Report on    Research Report on